
	Where results make sense

Topic: Meningococcal

Related Topics

Jerry Herman

Will Kymlicka

Oatley

Columbus, Ohio

McDonald County, Missouri

Lizard

Big Game

420s

In the News (Thu 31 Dec 09)

Northern Trust

Marvin Harrison

Peter Chernin

Gary Locke

Match Play

Penelope Cruz

Mickey Rourke

AR Rahman

Danny Boyle

Hugh Jackman

	Meningococcal - Vaccine Preventable Diseases - Immunization and Respiratory Infections Division (Site not responding. Last check: 2007-11-06)
		Clusters of cases of meningococcal disease in students have been reported in a number of countries, and carriage rates increase rapidly among freshmen during the first week of term in the U.K. In this age group in Canada, as in other countries, there is an increase in the rate of meningococcal disease.
		Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.
		Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
	www.phac-aspc.gc.ca /dird-dimr/vpd-mev/meningococcal_e.html (5290 words)

	NJDHSS, Communicable Diseases, Disease Fact Sheets: Meningococcal Invasive Disease
		Early meningococcal invasive disease may indeed look similar to a "bad cold." A parent should watch for changes that suggest the illness is becoming more severe than what the child has typically experienced in the past.
		Meningococcal infection can be diagnosed in several ways, including culture of the CSF (cerebrospinal fluid, the fluid which surrounds the brain) and culture of the blood.
		On October 20, 1999 the recommendations for use of the meningococcal vaccine in the United States were modified to include college freshmen residing in dormitories and other college students wishing to reduce their risk of meningococcal disease.
	www.state.nj.us /health/cd/f_mening.htm (861 words)

	Dr. Koop - Meningococcal Meningitis- Health Encyclopedia and Reference
		Meningococcal meningitis is a severe bacterial infection of the bloodstream and meninges (a thin lining covering the brain and spinal cord).
		Meningococcal meningitis occurs as a communicable disease between humans.
		A vaccine called meningococcal polysaccharide is used to prevent infection by certain groups of meningococcal bacteria.
	www.drkoop.com /encyclopedia/93/354.html (574 words)

	MENINGOCOCCAL
		Meningococcal disease is primarily a disease of young children.
		Adults at increased risk of meningococcal disease include those who have recently been brought together as a group and housed under crowded living conditions, such as in barracks or institutions.
		Meningococcal vaccine is effective on certain types of Neisseria meningitidis but is only recommended when there is a high incidence of cases in a limited geographic area and for persons traveling to countries where epidemics are in progress.
	www.idph.state.il.us /public/hb/hbmenin.htm (762 words)

	Meningitis, What is meningitis?
		Meningococcal meningitis, caused by Neisseria meningitidis, is primarily a disease of young children, with the incidence of cases declining in those older than 1 year of age.
		For meningococcal meningitis, household contacts and others who have had close personal contact with infected persons are recommended to receive a preventive antibiotic, often rifampin, which kills bacteria living in nose and throat secretions.
		Meningococcal vaccine is generally recommended only for persons traveling to other countries where epidemics are in progress, for military recruits and, rarely, in other circumstances.
	www.idph.state.il.us /public/hb/hbmening.htm (1135 words)

	Meningococcal Disease and Vaccination (Site not responding. Last check: 2007-11-06)
		Meningococcal disease is an invasive bacteria which presents as meningitis, or rarely, as chronic meningococcaemia or septic arthritis.
		Meningococcal disease is a severe infection that occurs when the meningococcal germ 'invades' the body from the throat or nose.
		Meningococcal septicaemia, also known as meningococcaemia, can be very serious and cause death after even a very short illness.
	www.health.gov.au /pubhlth/strateg/communic/factsheets/mening.htm (1650 words)

	MFA: Meningitis Foundation of America (Site not responding. Last check: 2007-11-06)
		Meningococcal meningitis is an infection caused by the bacterium Neisseria meningitidis, also known as meningococcus, which causes an inflammation of the membranes surrounding the brain and spinal cord.
		Neonates and infants are at a greater risk of meningococcal meningitis than any other age group due to deficiencies in their hummoral and cellular immunity and phagomatic function.
		Meningococcal meningitis is treated with intravenous antibiotics such as ceftriaxone or penicillin and oral antibiotics such as ciproflaxin or rifampin, until the infection's resistance to the drugs contradicts treatment.
	www.musa.org /faq_meningococcal.asp (1109 words)

	WHO \| Meningococcal meningitis
		The diagnosis of meningococcal meningitis is suspected by the clinical presentation and a lumbar puncture showing a purulent spinal fluid; sometimes the bacteria can be seen in microscopic examinations of the spinal fluid.
		Meningococcal meningitis occurs sporadically in small clusters throughout the world with seasonal variations and accounts for a variable proportion of endemic bacterial meningitis.
		The highest burden of meningococcal disease occurs in sub-Saharan Africa, which is known as the âMeningitis Beltâ, an area that stretches from Senegal in the west to Ethiopia in the east, with an estimated total population of 300 million people.
	www.who.int /mediacentre/factsheets/fs141/en (1678 words)

	A Commitment to Protect-Meningococcal (Site not responding. Last check: 2007-11-06)
		The most common forms of meningococcal disease are meningococcemia (blood infection) and meningitis, an infection of the membranes surrounding the brain and spinal cord.
		Meningococcal disease is easily spread through close contact with infected people, and outbreaks have occurred in schools, colleges, daycare centers, and similar settings.
		Meningococcal disease is associated with serious complications, including permanent brain damage, hearing loss, learning disability, loss of limbs, kidney failure, and death.
	www.vaccineprotection.com /consumer/diseases/meningococcal.cfm (453 words)

	eMedicine - Meningococcal Meningitis : Article by Francisco de Assis Aquino Gondim, MD, MSc, PhD (Site not responding. Last check: 2007-11-06)
		Meningococcal disease still is associated with a high mortality rate and persistent neurological defects, particularly among infants and young children.
		In Europe and the Americas, serogroup B is the predominant agent causing meningococcal disease, followed in frequency by serogroup C. Historically, serogroup A was the main cause of epidemic meningococcal disease globally, and serogroup A is still the predominant cause of meningococcal meningitis in Africa and Asia.
		Meningococcal meningitis is characterized by acute onset of intense headache, fever, nausea, vomiting, photophobia, and stiff neck.
	www.emedicine.com /NEURO/topic210.htm (4840 words)

	Meningitis.ca (Site not responding. Last check: 2007-11-06)
		Meningococcal disease is caused by a bacteria (a kind of germ) called Neisseria meningitidis.
		About three-quarters (75%) of meningococcal infections are meningitis, about 20% are meningococcal septicemia, and less than 5% are other forms of infection such as bacteremia (positive blood culture without serious illness), pneumonia, bone or joint infections.
		A person is susceptible to meningococcal disease if he or she has no immunity against the strain infecting the back of the nose and throat.
	www.meningitis.ca /whatismeningitis/meningococcal.asp (1545 words)

	MedlinePlus Drug Information: Meningococcal Polysaccharide Vaccine (Systemic) (Site not responding. Last check: 2007-11-06)
		Meningococcal polysaccharide (ma-nin-ja-KOK-kal pol-i-SAK-ka-ryd) vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria.
		Meningococcal polysaccharide vaccine is to be administered only by or under the supervision of your doctor or other health care professional.
		Childrenâ” In general the use of meningococcal vaccine is restricted to persons 2 years of age and older; however, in some cases children as young as 3 months of age may be vaccinated.
	www.nlm.nih.gov /medlineplus/druginfo/uspdi/202346.html (931 words)

	HPA - Infections \| Topics A-Z \| Meningitis / Meningococcal
		In the first groups to be immunised, confirmed serogroup C meningococcal disease has been dramatically reduced by up to 90% in 15-17 year olds and 82% in infants under the age of one year.
		Meningococcal disease has a case fatality rate of approximately 10%, however, more deaths are caused by septicaemia than by meningitis.
		As the vaccine does not protect against serogroup B meningococcal disease ( currently responsible for the majority of meningococcal infections), it is of the upmost importance that health professionals and the general public remain alert to the signs and symptoms of meningococcal disease.
	www.hpa.org.uk /infections/topics_az/meningo/backgrd.htm (976 words)

	Meningococcal Disease and College Students
		Forty-three cases of meningococcal disease were reported during the 2 years from colleges with a total enrollment of 4,393,744 students, for a low overall incidence of 1.0 per 100,000 population per year.
		The overall incidence of meningococcal disease in Maryland college students was similar to the incidence in the U.S. population of persons the same age (1.74/100,000 vs. 1.44/100,000, respectively); however, rates of disease were elevated among students living in dormitories compared with students living off-campus (3.2/100,000 vs. 0.96/100,000, p=0.05).
		The risk for meningococcal disease among college students is low; therefore, vaccination of all college students, all freshmen, or only freshmen who live in dormitories or residence halls is not likely to be cost-effective for society as a whole.
	www.cdc.gov /mmwr/preview/mmwrhtml/rr4907a2.htm (2706 words)

	NNii. Vaccine Information
		Close contacts of a person with meningococcal disease have a higher rate of infection and are at greatest risk in the first week of contact.
		In the U.S., meningococcal disease is usually caused by groups A, B, C, Y, and W-135 of the meningococcus bacteria.
		Meningococcal outbreak control is discussed in detail in CDC publications.
	www.immunizationinfo.org /vaccineInfo/vaccine_detail.cfv?id=15 (1556 words)

	Meningococcal Australia Inc
		Meningococcal Australia Inc is an Australian charitable organisation, established in February 2003, dedicated solely to fighting Meningococcal Disease through education and research and assisting those people whose lives have been ravaged by this terrible disease.
		Meningococcal Australia is the co-ordinating roof body of Foundations which have been established in Australia by individuals who have been directly affected through the loss of a loved one or who have been affected by having suffered the disease themselves.
		Meningococcal Australia Inc is funded through its Foundation Members – it does not raise funds or appeal for funds from the public.
	www.meningococcal-australia.org.au (289 words)

	The Facts about Meningococcal Disease
		Meningococcal disease refers to two conditions cause by the bacterium Neisseria meningitidis.
		Meningococcal meningitis is an inflammation of the meninges, the tissues that cover the brain and spinal cord.
		The meningococcal vaccine is recommended in some outbreak situations or for travel to areas of the world where high rates of the disease are known to occur.
	healthlink.mcw.edu /article/1031002419.html (585 words)

	Meningococcal Disease Prevention and Control Strategies for Practice-Based Physicians (Addendum: Recommendations for ...
		The incidence of meningococcal disease varies with age and is highest during the first year of life.
		Imrey PB, Jackson LA, Ludwinski PH, Meningococcal carriage, alcohol consumption, and campus bar patronage in a serogroup C meningococcal disease outbreak.
		Richmond P, Kaczmarski E, Borrow R, Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
	aappolicy.aappublications.org /cgi/content/full/pediatrics;106/6/1500 (3141 words)

	Meningococcal group C conjugate vaccines -- MAcLENNAN 84 (5): 383 -- Archives of Disease in Childhood
		Meningococcal disease at the University of Southampton: outbreak investigation.
		Bivalent A/C meningococcal conjugate vaccine in toddlers: persistence of antibodies and response to a polysaccharide vaccine booster (Poster 75) [abstract].
		Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a serogroup A and C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial.
	adc.bmjjournals.com /cgi/content/full/84/5/383 (3269 words)

	eMedicine - Meningococcal Infections : Article by Thomas A Hoffman, MD
		Public health officials arbitrarily define an outbreak of meningococcal disease as the occurrence of 3 or more cases during a period of 3 months or less with a primary attack rate of at least 10 cases per 100,000 population, which is approximately 10-fold greater than the normal occurrence.
		Meningococcal infection is probably introduced into families by adults who are asymptomatic, then spread through one or more household contacts to infect younger family members.
		The early stages of meningococcal disease may be misdiagnosed as a benign viral infection, and the patient may be discharged from an emergency department for care at home.
	www.emedicine.com /med/topic1444.htm (6909 words)

	Communicable Disease Fact Sheet
		Meningococcal disease is a severe bacterial infection of the bloodstream or meninges (a thin lining covering the brain and spinal cord) caused by the meningococcal germ.
		Anyone can get meningococcal disease, but it is more common in infants and children.
		High fever, headache, vomiting, stiff neck and a rash are symptoms of meningococcal disease.
	www.health.state.ny.us /nysdoh/communicable_diseases/en/menin.htm (627 words)

	DBMD - Meningococcal Disease - General Information
		Fortunately, none of the bacteria that cause meningitis are as contagious as things like the common cold or the flu, and they are not spread by casual contact or by simply breathing the air where a person with meningitis has been.
		People in the same household or day-care center, or anyone with direct contact with a patient's oral secretions (such as a boyfriend or girlfriend) would be considered at increased risk of acquiring the infection.
		College freshman, especially those who live in dormitories are at higher risk for meningococcal disease and should be educated about the availability of a safe and effective vaccine which can decrease their risk.
	www.cdc.gov /ncidod/dbmd/diseaseinfo/meningococcal_g.htm (866 words)

	The Children's Hospital at Westmead - Parents - Meningococcal infection (Site not responding. Last check: 2007-11-06)
		Children or young adults with meningococcal septicaemia are usually very ill. They have a high fever and can sometimes develop a red or purple rash (this looks like purple dots or bruises).
		Becoming sick with meningococcal disease is more likely in the very young, following a recent cold or with exposure to a lot of tobacco smoke, such as in indoors or in a car.
		However, as meningococcal infection is serious, if you suspect your child may have meningococcal infection because of the symptoms mentioned here, take to your child to your doctor or hospital straight away.
	www.chw.edu.au /parents/factsheets/mencoccj.htm (772 words)

	Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management -- van Deuren et al. 13 (1): 144 ...
		Meningococcal disease occurs worldwide as endemic infections ( 2, 80, 242, 346, 383, 421).
		meningococcal disease caused by serogroup A occurs in yearly recurrent
		In meningococcal infections, severe DIC is associated with a very poor prognosis ( 211, 507).
	cmr.asm.org /cgi/content/full/13/1/144 (10052 words)

	Meningococcal disease: Oh no, not another childhood vaccine -- Weir 166 (8): 1064 -- Canadian Medical Association ...
		Lingappa JR, Rosenstein N, Zell ER, Shutt KA, Schuchat A, Perkins B. Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.
		Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998.
		Meningococcal disease prevention and control strategies for practice-based physicians.
	www.cmaj.ca /cgi/content/full/166/8/1064 (1219 words)

	Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review -- Purcell et al. 328 ...
		Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis.
		Preventing secondary cases of meningococcal disease by identifying and eradicating disease-causing strains in close contacts of patients.
		Meningococcal disease: secondary attack rate and chemoprophylaxis in the United States, 1974.
	bmj.bmjjournals.com /cgi/content/full/328/7452/1339 (2902 words)

Try your search on: Qwika (all wikis)